HIGHLIGHTS
- What: The authors aimed to evaluate the safety of 68Ga-PSMA-11, administered using the injection kit for PET/CT imaging in a sample of Japanese patients with primary, recurrent, or suspected recurrent PC.
- Who: Anri Inaki from the Department of Nuclear Medicine, Kanazawa University Ishikawa, ‑8641, Japan have published the article: Evaluation of 68Ga-PSMA-11 PET/CT: a Phase 1 clinical study in Japanese patients with primary, recurrent, or suspected recurrent prostate cancer, in the Journal: (JOURNAL)
- How: The study was conducted in accordance with the ethical standards of the Declaration . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.